CiteULike: Zephyrus's Nielsen:TO [8 articles]

Supervised risk predictor of breast cancer based on intrinsic subtypes.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 8. (10 March 2009), pp. 1160-1167.

posted to therapy subtype prediction outcome cancer breast by Zephyrus on 2009-11-25 14:07:47 as

along with 3 people misonneh ptrobajo jfr

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

Breast Cancer Research and Treatment (10 February 2009)

by Shuzhen Liu, Stephen K. Chia, Erika Mehl, et al.Samuel Leung, Ashish Rajput, Maggie C. Cheang, Torsten O. Nielsen

posted to cancer outcome progesterone-receptor breast thelist superlist by Zephyrus on 2009-06-22 03:21:41 as

Gene Expression Profiling of Breast Cancer

Annual Review of Pathology: Mechanisms of Disease, Vol. 3, No. 1. (February 2008), pp. 67-97.

by Maggie C. Cheang, Matt van de Rijn, Torsten O. Nielsen

posted to cancer gene-expression review breast thelist by Zephyrus on 2009-05-29 18:29:55 as

along with 1 person laral

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Clin Cancer Res, Vol. 10, No. 16. (15 August 2004), pp. 5367-5374.

by T. O. Nielsen, F. D. Hsu, K. Jensen, et al.M. Cheang, G. Karaca, Z. Hu, T. Hernandez-Boussard, C. Livasy, D. Cowan, L. Dressler, L. A. Akslen, J. Ragaz, A. M. Gown, C. B. Gilks, M. van de Rijn, C. M. Perou

posted to basal biomarker cancer identification breast thelist by Zephyrus on 2009-05-18 20:49:42 as

along with 1 person jfr

Are triple-negative tumours and basal-like breast cancer synonymous?

Breast Cancer Research, Vol. 9 (30 November 2007), 404.

by Emad A. Rakha, David S. P. Tan, William D. Foulkes, et al.Ian O. Ellis, Andrew Tutt, Torsten O. Nielsen, Jorge S. Reis-Filho

posted to basal cancer check defref review triple-negative breast thelist by Zephyrus on 2009-04-27 13:43:23 as

Re-defining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease specific survival than estrogen receptor or HER-2 across all tumor subtypes

Breast Cancer Research, Vol. 10 (16 October 2008), R86.

by Golareh Habibi, Samuel Leung, Jennifer H. Law, et al.Karen Gelmon, Hamid Masoudi, Dmitry Turbin, Michael Pollak, Torsten O. Nielsen, David Huntsman, Sandra E. Dunn

posted to cancer estrogen her2 prediction prognosis receptor yb-1 breast thelist by Zephyrus on 2008-10-27 03:59:59 as

along with 1 group Breast Cancer Reading Club

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 5. (1 March 2008), pp. 1368-1376.

by Maggie C. Cheang, David Voduc, Chris Bajdik, et al.Samuel Leung, Steven McKinney, Stephen K. Chia, Charles M. Perou, Torsten O. Nielsen

posted to basal cancer comparisons prediction prognosis triple-negative biomarker breast thelist by Zephyrus on 2008-10-05 20:53:13 as

along with 4 people misonneh songpku NaliniChilkov jfr

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype

Human Pathology, Vol. 39, No. 10. (October 2008), pp. 1431-1437.

by David Voduc, Torsten O. Nielsen, Maggie C. Cheang, William D. Foulkes

posted to basal cancer cyclin-e journal-club phenotype skp2 pathway breast thelist by Zephyrus on 2008-09-16 16:36:13 as

along with 1 group Breast Cancer Reading Club

	Supervised risk predictor of breast cancer based on intrinsic subtypes. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 8. (10 March 2009), pp. 1160-1167. by Joel S. Parker, Michael Mullins, Maggie C. Cheang, et al.Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard posted to therapy subtype prediction outcome cancer breast by Zephyrus on 2009-11-25 14:07:47 as along with 3 people misonneh ptrobajo jfr
	Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients [My Copy] Breast Cancer Research and Treatment (10 February 2009) by Shuzhen Liu, Stephen K. Chia, Erika Mehl, et al.Samuel Leung, Ashish Rajput, Maggie C. Cheang, Torsten O. Nielsen posted to cancer outcome progesterone-receptor breast thelist superlist by Zephyrus on 2009-06-22 03:21:41 as
	Gene Expression Profiling of Breast Cancer [My Copy] Annual Review of Pathology: Mechanisms of Disease, Vol. 3, No. 1. (February 2008), pp. 67-97. by Maggie C. Cheang, Matt van de Rijn, Torsten O. Nielsen posted to cancer gene-expression review breast thelist by Zephyrus on 2009-05-29 18:29:55 as along with 1 person laral
	Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. [My Copy] Clin Cancer Res, Vol. 10, No. 16. (15 August 2004), pp. 5367-5374. by T. O. Nielsen, F. D. Hsu, K. Jensen, et al.M. Cheang, G. Karaca, Z. Hu, T. Hernandez-Boussard, C. Livasy, D. Cowan, L. Dressler, L. A. Akslen, J. Ragaz, A. M. Gown, C. B. Gilks, M. van de Rijn, C. M. Perou posted to basal biomarker cancer identification breast thelist by Zephyrus on 2009-05-18 20:49:42 as along with 1 person jfr
	Are triple-negative tumours and basal-like breast cancer synonymous? [My Copy] Breast Cancer Research, Vol. 9 (30 November 2007), 404. by Emad A. Rakha, David S. P. Tan, William D. Foulkes, et al.Ian O. Ellis, Andrew Tutt, Torsten O. Nielsen, Jorge S. Reis-Filho posted to basal cancer check defref review triple-negative breast thelist by Zephyrus on 2009-04-27 13:43:23 as
	Re-defining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease specific survival than estrogen receptor or HER-2 across all tumor subtypes [My Copy] Breast Cancer Research, Vol. 10 (16 October 2008), R86. by Golareh Habibi, Samuel Leung, Jennifer H. Law, et al.Karen Gelmon, Hamid Masoudi, Dmitry Turbin, Michael Pollak, Torsten O. Nielsen, David Huntsman, Sandra E. Dunn posted to cancer estrogen her2 prediction prognosis receptor yb-1 breast thelist by Zephyrus on 2008-10-27 03:59:59 as along with 1 group Breast Cancer Reading Club
	Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 5. (1 March 2008), pp. 1368-1376. by Maggie C. Cheang, David Voduc, Chris Bajdik, et al.Samuel Leung, Steven McKinney, Stephen K. Chia, Charles M. Perou, Torsten O. Nielsen posted to basal cancer comparisons prediction prognosis triple-negative biomarker breast thelist by Zephyrus on 2008-10-05 20:53:13 as along with 4 people misonneh songpku NaliniChilkov jfr
	The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype [My Copy] Human Pathology, Vol. 39, No. 10. (October 2008), pp. 1431-1437. by David Voduc, Torsten O. Nielsen, Maggie C. Cheang, William D. Foulkes posted to basal cancer cyclin-e journal-club phenotype skp2 pathway breast thelist by Zephyrus on 2008-09-16 16:36:13 as along with 1 group Breast Cancer Reading Club

Zephyrus's Nielsen:TO [8 articles] Export

Zephyrus's tags

thelist	2230
cancer	1843
breast	1488
superlist	1351
estrogen	709
review	641
background	441
evolution	356
read	328
cancer-crosstalk	251
treg	243
aggressiveness	229
xenoestrogen	217
th2	197
methods	196
immunomodulation	195
th1	194
hormone	184
immunology	157
dod	154
justification	149
therapy	145
autoimmune	139
genetics	138
immune	138
inflammation	136
gene-expression	135
epidemiology	133
receptor	127
estrogen-receptor	126
metastasis	126
statistics	125
mitochondria	124
prognosis	124
t-cell	122
list	112
primer	110
assay	105
confounder	102
endocrine	102
tumour	101
development	93
grade	89
aggressiveness-prediction	88
epigenetics	88
measurement	87
new-direction	84
apoptosis	81
disease	80
evolepi	79
microarray	75
mechanism	74
balance	73
obesity	69
molecular	66
africa	63
basal	63
cytokine	63
genetic	63
pregnancy	63
treg-background	63
check	62
interesting	62
polarization	62
pathway	61
survival	60
urgent	59
stress	58
neuroendocrine	57
gwas	55
signature	55
microenvironment	54
steroid	54
mice	53
risk	53
african-american	52
cell	52
gender-differences	52
perspective	52
reproductive	52
top	52
new-assay	51
environment	50
interaction	50
estrogen-tregs	49
pathology	49
genes	48
blood	47
population	47
progression	47
fetal	46
heterogeneity	45
hrt	45
disruption	44
prenatal	44
phytoestrogen	43
regulation	43
wira	43
dendritic	41
nutrition	41
selection	41
model	40
prediction	40
progesterone	40
immunosenescence	39
response	39
adipose	38
dna	38
genomics	38
snp	38
tools	38
senescence	37
th17	37
variation	37
age	35
natal	35
treg-cancer	35
microbiome	34
infection	33
ms	33
diet	32
bcdc	31
estrogenicity	31
peripheral	31
plasticity	31
biology	30
comparisons	30
research	30
signalling	30
web-study	30
her2	29
immunotherapy	29
metabolism	29
analysis	28
biomarker	28
disparities	28
energy	28
function	28
involution	28
suppression	28
transcription	28
association	27
carcinogenesis	27
eae	27
gender	27
ley	27
phenotype	27
polymorphisms	26
postmenopausal	26
allergy	25
cnv	25
dcis	25
foxp3	25
lymph	25
prostate	25
subsets	25
tamoxifen	25
xenobiotic	25
behaviour	24
commentary	24
hypothesis	24
morphology	24
receptor-status	24
brca	23
classification	23
comparison	23
defref	23
diabetes	23
exposure	23
macrophage	23
methylation	23
prolactin	23
reproduction	23
uterine	23
gut	22
hereditary	22
human	22
insulin	22
microrna	22
pre-malignant	22
proliferation	22
risk-factors	22
target	22
toll-like-receptor	22
triple-negative	22
angiogenesis	21
assay-defence	21
b-cell	21
chemotherapy	21
negative	21
node	21
prevention	21
resistance	21
vitd	21
characteristics	20
differentiation	20
estrogen-immune	20
genome	20
hiv	20
mtdna	20
sle	20
subtypes	20
bone	19
growth	19
guidelines	19
histology	19
immunity	19
journal-club	19
microbiota	19
race	19
stem-cell	19
uterus	19
16q	18
detection	18
height	18
male	18
outcome	18
system	18
treg-bc	18
validation	18
ageing	17
cd4	17
cgh	17
epithelium	17
expression	17
gene-environment	17
guidance	17
infectious	17
lung	17
migrant	17
power	17
stage	17
tissue	17
vaccine	17
antioxidant	16
autoimmunity	16
factors	16
incidence	16
malaria	16
menopause	16
premenopausal	16
protein	16
tgfb	16
aryl-hc	15
collinearity	15
ctc	15
immune-evasion	15
lifespan	15
mammography	15
mutation	15
nuclear	15
presentation	15
ra	15
serum	15
thymus	15
tolerance	15
usage	15
assessment	14
chemokines	14
escreen	14
immune-system	14
maternal	14
nigeria	14
progesterone-receptor	14
read-today	14
susceptibility	14
beta	13
book	13
cell-cycle	13
clinical	13
data-analysis	13
disruptors	13
dormancy	13
er-calux	13
estradiol	13
lymphocyte	13
metabolic	13
prognosis-bc	13
regression	13
sample-size	13
signaling	13
size	13
studies	13
testosterone	13
xenoestrogen-immune	13
action	12
advice	12
aromatase	12
brain	12
cardiac	12
case-control	12
death	12
for:songpku	12
gene-list	12
genetic-basis	12
genistein	12
genotype	12
grade-is-best	12
histopathology	12
homeostasis	12
homework	12
ifn-gamma	12
innate	12
in-vitro	12
mcf-7	12
nottingham	12
outbreak	12
programming	12
reference	12
restriction	12
warburg	12
androgen	11
caucasian	11
database	11
distinction	11
endemic	11
gene-gene-interactions	11
grade-prognosis	11
growth-factors	11
il17	11
instability	11
ki67	11
latent	11
markers	11
melanoma	11
mixture-effects	11
mortality	11
neonatal	11
nsaid	11
physiology	11
plasma	11
screening	11
ses	11
tnfa	11
apc	10
bacteria	10
colorectal	10
complex	10
correlation	10
diversity	10
dtc	10
endometriosis	10
haplotype	10
heterogeneity-bc	10
immunohistochemistry	10
leukocytes	10
menarche	10
neutrophil	10
nk-cells	10
pathogenesis	10
pituitary	10
proteomics	10
software	10
soy	10
til	10
xenoestrogen-bc	10
activation	9
adaptive	9
amplification	9
ancestry	9
anti-inflammatory	9
bioinformatics	9
bone-marrow	9
brca1	9
breast-feeding	9
cell-death	9
clinical-significance	9
cytokeratin	9
density	9
distribution	9
er	9
estrogen-basic	9
factor	9
fat	9
future	9
hypoxia	9
il4	9
il6	9
leptin	9
levels	9
lobular	9
mapping	9
nf-kappab	9
nitric-oxide	9
opinion	9
outcomes	9
pathways	9
pregnancy-associated-breast-cancer	9
profile	9
reliability	9
science	9
smoking	9
stroma	9
surgery	9
toxicology	9
traffic	9
alcohol	8
calorie	8
candidate	8
cox2	8
darwin	8
diagnosis	8
editorial	8
emt	8
er-alpha	8
ere	8
estrogen-level	8
ethnicity	8
etiology	8
european	8
flow-cytometry	8
future-research	8
general	8
il2	8
iron	8
isoflavone	8
limitations	8
mammary	8
meta-analysis	8
migration	8
modulation	8
old-wine-new-bottle	8
origin	8
oxidative	8
p53	8
pca	8
perinatal	8
protocol	8
recurrence	8
repair	8
rna	8
seer	8
starting-point	8
status	8
stem	8
tumor	8
weight	8
additivity	7
ahr	7
antigen	7
asian	7
asthma	7
axis	7
bisphenol-a	7
brca2	7
cmi	7
concepts	7
critique	7
damage	7
demography	7
dysfunction	7
effects	7
endogenous	7
environmental	7
er-beta	7
esr1	7
estrogen-action	7
feto-maternal	7
gene-reporter	7
history	7
hypothalamus	7
identification	7
immunotoxicity	7
impact	7
imprinting	7
inflammatory	7
inuit	7
lifestyle	7
melatonin	7
menstruation	7
nodes	7
organogenesis	7
origins	7
pd-1	7
postnatal	7
predictive-adaptive	7
public-abstract	7
resource	7
ros	7
significance	7
syndrome	7
trends	7
virus	7
writing	7
yeast	7
anergy	6
bcl2	6
biomarkers	6
cell-line	6
climate	6
cns	6
early	6
early-life	6
epistasis	6
female	6
gene-reporter-assay	6
genomic	6
histopath	6
host	6